Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now early-phase tilt small index

Hypoxemia: early-phase trial registry

5 of 11 indexed Hypoxemia trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,577 of 28,707 conditions by registered trial count.

11 US clinical trials · 5 currently recruiting · #1,577 of 28,707 conditions by registered trial count

Hypoxemia: 11 US clinical trials tracked, 5 recruiting.

Hypoxemia is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Colorado, Denver, running 2 of these trials.

Enrollment posture brief

Registry condition hypoxemia

OPEN 5 | RECR 45% | LATE 0 | EARLY 1 | RANK #1577 | SPON 2

Nearest open-share peer: Advanced Breast Carcinoma (45% recruiting · 11 trials)

Acute Pancreatitis81.8%Acute Stroke45.5%Hypoxemia (this)45%Acquired Brain Injury36.4%Acute Lung Injury9.1%
Open-enrollment share among volume-matched conditions near Hypoxemia

Hypoxemia lists 5 open slots (45% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Hypoxemia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Hypoxemia recruits in line with its size-band peers.

    5 of 11 indexed trials (45.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Hypoxemia research.

    University of Colorado, Denver accounts for 2 of 11 trials (18.2%). 10 distinct sponsors appear on at least one study for this condition label.

  3. Most Hypoxemia trials plan to enrol fewer than 100 people.

    Median target enrolment is 89 among the 11 trials that report a genuine target (sentinel values excluded). 7 of those (63.6%) plan for fewer than 100 participants.

  4. Hypoxemia splits between interventional and observational designs.

    7 interventional and 4 observational studies make up this index (63.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Open and recent trials

11 total, page 1 of 1

RECRUITING NA 3,600 participants

Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients

University of Colorado, Denver

NCT06501118

RECRUITING NA 152 participants

Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE)

Masimo Corporation

NCT06432881

RECRUITING 92 participants

Skin Pigment/Pulse Oximeter in Congenital Heart Disease (CHD)

Icahn School of Medicine at Mount Sinai

NCT06575270

RECRUITING 30 participants

Postoperative Respiratory and Activity Monitoring

University of Colorado, Denver

NCT06239831

RECRUITING Phase 2 10 participants

Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia

Bastiaan Driehuys

NCT07037836

ACTIVE NOT RECRUITING 39 participants

Work of Breathing Assessment in Triage Scale

CHRISTUS Health

NCT05479929

ACTIVE NOT RECRUITING NA 20 participants

Rebreathing-induced Hypoxia and Glucose Levels

University of Texas at Austin

NCT05422430

COMPLETED NA 680 participants

Nasotracheal Intubation With VL vs DL in Infants Trial

Children's Hospital of Philadelphia

NCT05433155

COMPLETED 232 participants

Oximeters and Skin Pigment: Impact of Skin Pigmentation on Accuracy of Pulse Oximetry

University of Cincinnati

NCT05690269

COMPLETED NA 89 participants

Pulse Oximetry With Automated Verbal Prompts

University of Florida

NCT02930863

COMPLETED NA 11 participants

Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest

Johns Hopkins University

NCT04170062

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Hypoxemia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

SpO2 and SaO2 comparison Device
1 trials
Nasotracheal intubation Device
1 trials
Brief post-PACU stay survey. Behavioral
1 trials
pulse oximetry software Other
1 trials
Nasal Delivery of Oxygen Therapy Device
1 trials
Nasal Delivery of High-Flow Air and Oxygen Therapy Device
1 trials
Spontaneous breathing Behavioral
1 trials
Rebreathing-induced hypoxia Behavioral
1 trials

US sites by state

Facility locations filed on Hypoxemia trials. A trial with sites in several states counts in each.

Texas 3 trials
Colorado 3 trials
Washington 1 trials
Tennessee 1 trials
South Carolina 1 trials
Pennsylvania 1 trials
Ohio 1 trials
New York 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Hypoxemia page

11 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hypoxemia condition card totals 11 registered trials; most-linked intervention SpO2 and SaO2 comparison; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.